We are live on ! Find out more
ARTLW

Artelo Biosciences, Inc. Warrant
ARTLW

Delisted

ARTLW was delisted on the 17th of June, 2024.

Back to rankings

3 hedge funds and large institutions have $5K invested in Artelo Biosciences, Inc. Warrant in 2022 Q3 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

40% less funds holding

Funds holding: 5 → 3 (-2)

97% less capital invested

Capital invested by funds: $169K → $5K (-$164K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
3
Holders Change
-2
Holders Change %
-40%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
-$2K
Name Holding Trade Value Shares
Change 		Change in
Stake
Verition Fund Management
1
Verition Fund Management
Connecticut
$4K – – –
AGM
2
Alpine Global Management
New York
$1K – -1 -0%
VF
3
Virtu Financial
New York
– -$2K -19,027 Closed

ARTLW Hedge Fund Activity: Q3 2022 in Review

3 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Artelo Biosciences, Inc. Warrant (ARTLW) for Q3 2022, worth a combined $5K — down 97% from $169K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of ARTLW and 0 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 0 added.

The largest seller was Virtu Financial, exiting entirely with an estimated $2K sold.

  • 3 institutional investors held Artelo Biosciences, Inc. Warrant (ARTLW) as of Q3 2022, down from 5 in Q2 2022.
  • Funds reported $5K of Artelo Biosciences, Inc. Warrant stock for Q3 2022, down 97% quarter-over-quarter.
  • 0 funds opened new Artelo Biosciences, Inc. Warrant positions in Q3 2022 and 2 closed out, a net change of -2 holders.
  • The largest Artelo Biosciences, Inc. Warrant seller in Q3 2022 was Virtu Financial, an estimated $2K sold.

Based on aggregated 13F filings for Q3 2022.